ABOUT MAESTRO
Maestro is managed by seasoned US pharmaceutical industry leaders with the requisite expertise in design and execution of pivotal clinical studies that can stand the scrutiny of the international clinical science community and that can support US and European regulatory submissions.
Maestro is building a dedicated research staff in China that combines individuals experienced in and intimately familiar with Western GCP research practice with those who are familiar with and understand both the delivery of healthcare and the current conduct of clinical research in Chinese medical centers. This full time staff provides the essential support to individual sites in the Consortium that make possible impeccable, GCP-compliant execution of clinical studies.
Maestro is also establishing rigorous training programs for key research personnel at Consortium sites, including Principal Investigators, Co-Investigators, Research Coordinators and ancillary care providers.
